| Mallory Scogin, MD | |
|
800 Saint Vincents Dr Ste 600, Birmingham, AL 35205-1630 | |
| (205) 271-1600 | |
| (205) 271-3180 |
| Full Name | Mallory Scogin |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 10 Years |
| Location | 800 Saint Vincents Dr Ste 600, Birmingham, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114312840 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 38082 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| D C H Regional Medical Center | Tuscaloosa, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Capstone Health Services Foundation Pc | 6103724489 | 120 |
News Archive
Galectin Therapeutics, the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, announced details today on its first-in-man Phase 1 clinical trial that will support a proposed indication of GR-MD-02 for treatment of non-alcoholic steatohepatitis (NASH, or fatty liver disease) with advanced fibrosis.
A new biochip technology could eliminate animal testing in the chemicals and cosmetics industries, and drastically curtail its use in the development of new pharmaceuticals, according to new findings from a team of researchers at Rensselaer Polytechnic Institute, the University of California at Berkeley, and Solidus Biosciences Inc.
A new era in pediatric and adolescent healthcare began today at Children's Hospital Los Angeles when 191 inpatients were carefully moved into its new 317-bed, $636 million state-of-the-art hospital building.
Researchers have found an unexpected synergy between a T-cell stimulatory protein - the ICOS ligand - and interleukin-10, an immunoregulatory cytokine, to prevent inflammatory bowel disease in mice.
› Verified 4 days ago
| Entity Name | Dch Health Care Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841394418 PECOS PAC ID: 8123924248 Enrollment ID: O20040204000874 |
News Archive
Galectin Therapeutics, the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, announced details today on its first-in-man Phase 1 clinical trial that will support a proposed indication of GR-MD-02 for treatment of non-alcoholic steatohepatitis (NASH, or fatty liver disease) with advanced fibrosis.
A new biochip technology could eliminate animal testing in the chemicals and cosmetics industries, and drastically curtail its use in the development of new pharmaceuticals, according to new findings from a team of researchers at Rensselaer Polytechnic Institute, the University of California at Berkeley, and Solidus Biosciences Inc.
A new era in pediatric and adolescent healthcare began today at Children's Hospital Los Angeles when 191 inpatients were carefully moved into its new 317-bed, $636 million state-of-the-art hospital building.
Researchers have found an unexpected synergy between a T-cell stimulatory protein - the ICOS ligand - and interleukin-10, an immunoregulatory cytokine, to prevent inflammatory bowel disease in mice.
› Verified 4 days ago
| Entity Name | Capstone Health Services Foundation Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740397751 PECOS PAC ID: 6103724489 Enrollment ID: O20040330001160 |
News Archive
Galectin Therapeutics, the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, announced details today on its first-in-man Phase 1 clinical trial that will support a proposed indication of GR-MD-02 for treatment of non-alcoholic steatohepatitis (NASH, or fatty liver disease) with advanced fibrosis.
A new biochip technology could eliminate animal testing in the chemicals and cosmetics industries, and drastically curtail its use in the development of new pharmaceuticals, according to new findings from a team of researchers at Rensselaer Polytechnic Institute, the University of California at Berkeley, and Solidus Biosciences Inc.
A new era in pediatric and adolescent healthcare began today at Children's Hospital Los Angeles when 191 inpatients were carefully moved into its new 317-bed, $636 million state-of-the-art hospital building.
Researchers have found an unexpected synergy between a T-cell stimulatory protein - the ICOS ligand - and interleukin-10, an immunoregulatory cytokine, to prevent inflammatory bowel disease in mice.
› Verified 4 days ago
| Entity Name | Ob-gyn Associates Of Alabama P C |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346250537 PECOS PAC ID: 2961476254 Enrollment ID: O20040823001014 |
News Archive
Galectin Therapeutics, the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, announced details today on its first-in-man Phase 1 clinical trial that will support a proposed indication of GR-MD-02 for treatment of non-alcoholic steatohepatitis (NASH, or fatty liver disease) with advanced fibrosis.
A new biochip technology could eliminate animal testing in the chemicals and cosmetics industries, and drastically curtail its use in the development of new pharmaceuticals, according to new findings from a team of researchers at Rensselaer Polytechnic Institute, the University of California at Berkeley, and Solidus Biosciences Inc.
A new era in pediatric and adolescent healthcare began today at Children's Hospital Los Angeles when 191 inpatients were carefully moved into its new 317-bed, $636 million state-of-the-art hospital building.
Researchers have found an unexpected synergy between a T-cell stimulatory protein - the ICOS ligand - and interleukin-10, an immunoregulatory cytokine, to prevent inflammatory bowel disease in mice.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mallory Scogin, MD 800 Saint Vincents Dr Ste 600, Birmingham, AL 35205-1630 Ph: (205) 271-1600 | Mallory Scogin, MD 800 Saint Vincents Dr Ste 600, Birmingham, AL 35205-1630 Ph: (205) 271-1600 |
News Archive
Galectin Therapeutics, the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, announced details today on its first-in-man Phase 1 clinical trial that will support a proposed indication of GR-MD-02 for treatment of non-alcoholic steatohepatitis (NASH, or fatty liver disease) with advanced fibrosis.
A new biochip technology could eliminate animal testing in the chemicals and cosmetics industries, and drastically curtail its use in the development of new pharmaceuticals, according to new findings from a team of researchers at Rensselaer Polytechnic Institute, the University of California at Berkeley, and Solidus Biosciences Inc.
A new era in pediatric and adolescent healthcare began today at Children's Hospital Los Angeles when 191 inpatients were carefully moved into its new 317-bed, $636 million state-of-the-art hospital building.
Researchers have found an unexpected synergy between a T-cell stimulatory protein - the ICOS ligand - and interleukin-10, an immunoregulatory cytokine, to prevent inflammatory bowel disease in mice.
› Verified 4 days ago
James R Dollar, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 48 Medical Park Dr E, Suite 355, Birmingham, AL 35235 Phone: 205-838-3036 Fax: 205-838-5832 | |
Richard Own Burney, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1700 6th Ave S, Birmingham, AL 35233 Phone: 205-996-3130 | |
Sarah Fort Whitehead, M.D. Obstetrics & Gynecology Medicare: May Accept Medicare Assignments Practice Location: 2006 Brookwood Med Ctr Dr Ste 700, Birmingham, AL 35209 Phone: 205-397-1286 Fax: 205-397-1340 | |
Kimberly Hoover, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Percy Charles Hudson, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 806 Saint Vincents Dr, Suite 430, Birmingham, AL 35205 Phone: 205-939-2806 | |
Isuzu Meyer, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Sarah Dunk, Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-934-4011 |